EuroMedtech EBD Group EuroMedtech
Share:
Email this page Share this on LinkedIn Share this on Twitter

EuroMedtech™ 2014 Press Releases

May 15, 2014EuroMedtech™ 2014 reports an 82% increase in licensable assets and technologies brought to partner The sixth annual EuroMedtech partnering conference, held May 7–8, 2014, wrapped up in Linz, Austria last week. The event reported an 82% increase in licensing opportunities at the event, indicating a surge in medtech innovation and the increasing role of collaboration in medtech industry business strategies. "The event was buzzing with activity this year, with substan...  more ►

April 22, 2014EuroMedtech™ 2014 presenting companies bring cutting edge medical technologies to potential partners The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. The Presenting Companies track provides a pipeline to innovative companies interested in partnering their technologies...  more ►

April 1, 2014EuroMedtech™ 2014 announces pre-conference business development workshop and May 8 special Diagnostics session The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. A pre-conference Business Development Workshop entitled "Effective Innovation Portfolio Management for Medical Device ...  more ►

March 26, 2014Spotlight on Linz Business Facts A top European location for health technology: From blood sugar tests to wheelchairs, CT scanners to syringes—medical technology companies in Austria can be found in each and every specialized field of the sector. A thriving medical technology economy: A total of 433 companies in the Upper Austrian region can be related in one way or another to the field of medical techn...  more ►

February 6, 2014EuroMedtech™ 2014 brings leaders in medical device innovation to Linz, Austria this May The sixth annual EuroMedtech 2014 partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference where participants engage with potential partners around in- and out-licensing of products and IP, financing and other collaborative programs. The 2013 event attracted 261 dealmakers from 191 comp...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►

July 28, 2014 Deal trends in Regenerative Medicine The field of regenerative medicine is an up-and-coming new approach for targeting and treating diseases, involving the repair and restoration of previously damaged tissues or organs in the body. According to the Current Agreements life science deals and alliance database, there have been over 700 regenerative medicine/stem cell deals in the last five years alone. more ►

July 22, 2014 Promethera expands portfolio with progenitor cell platform Eric Halioua arrives at BioPharm America™ in Boston this September carrying an expanding portfolio of partnering opportunities based on a platform of human liver progenitor cells. more ►

July 22, 2014 CoStim Pharma: People plus hot science create stunning combo-combo deal Pathways and platforms are great but true exits come around product portfolios, says Robert Millman, a founder and the chief executive for CoStim Pharmaceuticals, which was snapped up by Novartis just 10 months after the company's first funding round. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
EuroMedtech EBD Group EuroMedtech